Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug ...
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
A new Idaho law that goes into effect in January reforms pharmacy benefit managers to increase transparency and cut ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback